OBI Pharma granted FDA ODD for OBI-888

Drug Discovery |  News | 0 Comment | 21 Nov, 2018

OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of P...Read more

Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities

Drug Discovery |  News | 0 Comment | 15 Nov, 2018

Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is has acquired the biophysics specialists, Kinetic Discovery, a privat...Read more

MEI Pharma, KHK to develop and commercialize ME-401

Drug Discovery |  News | 0 Comment | 05 Nov, 2018

MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK exclusive rights to develop and commercialize ME-401 in Japan. ME-40...Read more

FDA OKs J&J's Invokana for heart conditions

Drug Discovery |  News | 0 Comment | 31 Oct, 2018

Singapore –  The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INVOKANA (canagliflozin) t...Read more

Halozyme licenses $25M drug delivery technology to Roche

Drug Discovery |  News | 0 Comment | 30 Oct, 2018

Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusive development of a new undisclosed drug target with an option to add...Read more

Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain

Drug Discovery |  News | 0 Comment | 24 Oct, 2018

Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reporte...Read more

FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

Drug Discovery |  News | 0 Comment | 22 Oct, 2018

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) as add-on maintenance therapy in patients with moderate-to-severe asth...Read more

Roche's Tecentriq extends progression-free survival in TNBC

Drug Discovery |  News | 0 Comment | 22 Oct, 2018

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (atezolizumab) plus Celgene's ABRAXANE (nab-paclitaxel) in patients wi...Read more

Ostrich antibody as dengue fever solution ready for commercialization

Drug Discovery |  News | 0 Comment | 22 Oct, 2018

Singapore - MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four serotypes of Dengue Viruses; providing a new avenue for dengue prevent...Read more

Strides Pharma gets USFDA nod for its anti-epileptic drug

Drug Discovery |  News | 0 Comment | 22 Oct, 2018

Strides Pharma Science (Strides) on Saturday announced that its global arm Strides Pharma Global Pte Singapore has received USFDA approval for Gabapentin capsules. Gabapentin capsules is a...Read more

Eisai discovers new compound to treat Parkinson's disease

Drug Discovery |  News | 0 Comment | 19 Oct, 2018

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a rese...Read more

Axsome receives FDA Orphan Drug designation for narcolepsy drug

Drug Discovery |  News | 0 Comment | 17 Oct, 2018

Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received on Tu...Read more

FDA issues new guidance for developers of complex generics

Drug Discovery |  News | 0 Comment | 10 Oct, 2018

 Singapore - The FDA has released new guidance documents aimed at advancing development of generic versions of transdermally and topically administered drugs, formulations th...Read more

Novartis’ crizanlizumab relieves patients from sickle cell pain crisis

Drug Discovery |  News | 0 Comment | 10 Oct, 2018

Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal antibody being investigated for the treatment of sickle cell disease ...Read more

J&J abandons partnership for Geron’s cancer drug

Drug Discovery |  News | 0 Comment | 04 Oct, 2018

Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat, wiping two-thirds off the biotechs share price at a stroke. J&...Read more

New drug blocks pancreatic cancer growth

Drug Discovery |  News | 0 Comment | 28 Sep, 2018

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai.  The study, publi...Read more

Alexion to acquire Syntimmune

Drug Discovery |  News | 0 Comment | 26 Sep, 2018

Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing antibody therapeutics ta...Read more

Anaeropharma Science signs research agreement with Astellas

Drug Discovery |  News | 0 Comment | 25 Sep, 2018

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Astellas Pharma Inc. headquartered in Tokyo (hereafter "Astellas") ...Read more